A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL DIFELIKEFALIN (CR845) FOR MODERATE TO SEVERE PRURITUS IN ADULT SUBJECTS WITH ATOPIC DERMATITIS

Registry ID

CR845-210501

Source registry

HEALTH_CANADA

Status

Closed

Study type

INTERVENTIONAL

Sponsor

CARA THERAPEUTICS

Start date

2021-03-01

Completion date

2021-07-23

Last update

2020-05-12

Conditions

• PRURITIS

Related clinical trials

• AN EXPLORATORY PROOF OF CONCEPT STUDY TO ASSESS THE PHARMACOKINETICS/PHARMACODYNAMICS OF NEMOLIZUMAB (CD14152) IN ADULT PARTICIPANTS WITH CHRONIC PRURITUS OF UNKNOWN ORIGIN (CPUO)
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB FOR THE TREATMENT OF PRURITUS OF LICHEN SIMPLEX CHRONICUS (LSC) IN ADULTS
• ¿MASTER PROTOCOL OF TWO RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, MULTI-CENTER, PARALLEL GROUP STUDIES TO EVALUATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT PATIENTS WITH CHRONIC PRURITUS OF UNKNOWN ORIGIN (CPUO)¿
• LONG-TERM SAFETY AND TOLERABILITY STUDY OF LINERIXIBAT FOR THE TREATMENT OF CHOLESTATIC PRURITUS IN PARTICIPANTS WITH PRIMARY BILIARY CHOLANGITIS.

View on source registry